Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models

Science

Volumn 344, Issue 6188, 2014, Pages 1178-1182

  Chun, Sungkun ^a   Westmoreland, Joby J ^a   Bayazitov, Ildar T ^a   Eddins, Donnie ^a   Pani, Amar K ^a   Smeyne, Richard J ^a   Yu, Jing ^a   Blundon, Jay A ^a   Zakharenko, Stanislav S ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; NEUROLEPTIC AGENT; DGCR8 PROTEIN, MOUSE; DOPAMINE 2 RECEPTOR; RNA BINDING PROTEIN;

RNA; RODENT; THEORETICAL STUDY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY CORTEX; CHROMOSOME DELETION 22Q11; GENE DELETION; HAPLOINSUFFICIENCY; HUMAN; HYPERSENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; THALAMOCORTICAL TRACT; THALAMUS; 22Q11 DELETION SYNDROME; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG RESISTANCE; GENETICS; METABOLISM; MUTANT MOUSE STRAIN;

22Q11 DELETION SYNDROME; ANIMALS; ANTIPSYCHOTIC AGENTS; AUDITORY CORTEX; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; HAPLOINSUFFICIENCY; MICE; MICE, MUTANT STRAINS; MICRORNAS; RECEPTORS, DOPAMINE D2; RNA-BINDING PROTEINS; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; THALAMUS;

EID: 84901853724     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1253895     Document Type: Article

References (14)

1. T. R. Insel, Nature 468, 187-193 (2010).
2. A. Carlsson, Neuropsychopharmacology 1, 179-186 (1988).
3. S. H. Snyder, Philos. Trans. R. Soc. London Ser. B 354, 1985-1994 (1999).
4. S. Miyamoto, N. Miyake, L. F. Jarskog, W. W. Fleischhacker, J. A. Lieberman, Mol. Psychiatry 17, 1206-1227 (2012).
5. T. Dierks et al., Neuron 22, 615-621 (1999).
6. D. Hubl, T. Koenig, W. K. Strik, L. M. Garcia, T. Dierks, Br. J. Psychiatry 190, 57-62 (2007).
7. E. A. Lindsay et al., Nature 401, 379-383 (1999).
8. E. A. Lindsay et al., Nature 410, 97-101 (2001).
9. 22q11DS is caused by the hemizygous deletion of a 1.5- to 3-megabase region of the q arm of human chromosome 22, and SCZ develops in approximately 30% of patients with 22q11DS. Df(16)1/+ mice carry a hemizygous deletion of 23 genes in the syntenic region of chromosome 16.
10. P. H. Smith, L. C. Populin, J. Comp. Neurol. 436, 508-519 (2001).
11. S. S. Zakharenko, L. Zablow, S. A. Siegelbaum, Nat. Neurosci. 4, 711-717 (2001).
12. J. T. Coyle, Harv. Rev. Psychiatry 3, 241-253 (1996).
13. N. D. Woodward, H. Karbasforoushan, S. Heckers, Am. J. Psychiatry 169, 1092-1099 (2012).
14. R. P. Behrendt, Conscious. Cogn. 12, 413-451 (2003).